Roberto Mignone, an insider at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 367,600 shares of the company's stock on September 18, 2026. The transactions, executed at an average price of $39.06 per share, amounted to a total value of approximately $14.36 million.
This sale represents a notable divestment by an executive within Teva. Insider sales can be motivated by a variety of reasons, including personal financial planning, diversification of assets, or adherence to pre-established trading schedules, and do not inherently signal a negative view of the company's prospects.
Other recent insider activity at TEVA includes smaller sales by Brian Savage and Ronit Satchi-Fainaro, as reported in the company's filings.